Does RUCAPARIB CAMSYLATE Cause Hepatic enzyme increased? 176 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 176 reports of Hepatic enzyme increased have been filed in association with RUCAPARIB CAMSYLATE (Rubraca). This represents 2.1% of all adverse event reports for RUCAPARIB CAMSYLATE.
176
Reports of Hepatic enzyme increased with RUCAPARIB CAMSYLATE
2.1%
of all RUCAPARIB CAMSYLATE reports
1
Deaths
24
Hospitalizations
How Dangerous Is Hepatic enzyme increased From RUCAPARIB CAMSYLATE?
Of the 176 reports, 1 (0.6%) resulted in death, 24 (13.6%) required hospitalization.
Is Hepatic enzyme increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUCAPARIB CAMSYLATE. However, 176 reports have been filed with the FAERS database.
What Other Side Effects Does RUCAPARIB CAMSYLATE Cause?
Fatigue (2,494)
Nausea (2,219)
Malignant neoplasm progression (1,162)
Decreased appetite (787)
Constipation (763)
Diarrhoea (759)
Vomiting (759)
Asthenia (660)
Adverse event (571)
Carbohydrate antigen 125 increased (562)
What Other Drugs Cause Hepatic enzyme increased?
METHOTREXATE (9,857)
ADALIMUMAB (8,693)
TOCILIZUMAB (7,691)
ETANERCEPT (7,481)
ABATACEPT (7,397)
RITUXIMAB (7,247)
LEFLUNOMIDE (7,173)
INFLIXIMAB (6,778)
HYDROXYCHLOROQUINE (6,555)
TOFACITINIB (6,269)
Which RUCAPARIB CAMSYLATE Alternatives Have Lower Hepatic enzyme increased Risk?
RUCAPARIB CAMSYLATE vs RUFINAMIDE
RUCAPARIB CAMSYLATE vs RUPATADINE
RUCAPARIB CAMSYLATE vs RUXOLITINIB
RUCAPARIB CAMSYLATE vs SABRIL
RUCAPARIB CAMSYLATE vs SACCHAROMYCES CEREVISIAE